Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Pfizer
Woman and Man Max 99 years
Pfizer Ltd, Ramsgate Road,Sandwich,Kent CT13 9NJ
Update Il y a 4 ans
A RANDOMIZED, MULTICENTRE, DOUBLE BLIND, PLACEBO CONTROLLED STUDY EVALUATING THE EFFICACY OF VARENICLINE IN CESSATION OF ORAL TOBACCO USE
To compare the efficacy of varenicline to placebo for cessation of use of smokeless tobacco assessed using the 4 week Continuous Quit Rate (CQR) at the end of treatment.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
Pfizer
Update Il y a 6 ans
Etude EMBARK : étude visant à comparer l’efficacité et la sécurité d’emploi de l’enzalutamide en monothérapie et associé à la leuproréline, à l’association d’un placebo et de la leuproréline, chez des patients ayant un cancer de la prostate non métastatique à haut risque de progression après un traitement définitif.
La prostate est une glande de l’appareil reproducteur masculin. Elle est située sous la vessie et, comme un anneau, elle entoure l’urètre, canal par lequel l’urine et le sperme sortent à l’extérieur d...
Country
France
organs
Prostate
Specialty
Chimiothérapie
Essai ouvert aux inclusions
More information
Woman Max 99 years
Pfizer Inc.235 East 42nd Street, New York, NY 10017
Update Il y a 4 ans
PHASE 2 STUDY OF SINGLE-AGENT PF 03084014 IN PATIENTS WITH ADVANCED TRIPLE-NEGATIVE BREAST CANCER WITH OR WITHOUT GENOMIC ALTERATIONS IN NOTCH RECEPTORS
•To estimate the objective response rate (ORR) of PF-03084014 when given as a single agent in the treatment of patients with advanced TNBC harboring genomic alterations in Notch receptors (NA+).
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer Inc.235 East 42nd Street, New York, NY 10017
Update Il y a 4 ans
Study to test the safety and efficacy of PF-04449913 with azacitidine versus placebo with azacitidine in patients with Intermediate-2 or high risk myelodysplastic syndrome, acute myeloid leukemia with 20-30% blasts and multi-lineage dysplasia, or chronic myelomonocytic
Primary Objectives for the Phase 1b (Safety Lead-In) •To assess the safety and tolerability of PF 04449913 when administered in combination with azacitidine in patients with previously untreated Inte...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Pfizer Inc.235 East 42nd Street, New York, NY 10017
Update Il y a 4 ans
A FOUR WEEK, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 2A STUDY OF VARENICLINE TARTRATE (CP-526,555) IN THE TREATMENT OF POST-HERPETIC NEURALGIA
1.To evaluate the analgesic efficacy of varenicline versus placebo in patients with postherpetic neuralgia (PHN) 2.To evaluate the safety and tolerability of varenicline versus placebo in patients w...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Pfizer Ltd, Ramsgate Road, Sandwich, Kent. UK
Update Il y a 4 ans
A PHASE 2a MULTI-CENTRE, DOUBLE BLIND, PLACEBO CONTROLLED CROSS-OVER TRIAL TO INVESTIGATE THE EFFICACY, SAFETY AND TOLERATION OF CP-866,087 IN PRE-MENOPAUSAL WOMEN DIAGNOSED WITH FEMALE SEXUAL AROUSAL DISORDER (FSAD)
Assess the effect of 3 doses (1, 3 and 10 mg) of CP-866,087 vs. placebo on female arousal, desire, orgasm and distress in pre-menopausal women on oral contraceptives suffering primarily from Female Se...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
Pfizer
Update Il y a 4 ans
Étude B7391003 : étude de phase 3, randomisée, en double aveugle évaluant le Pf- 06439535 associé au paclitaxel et au carboplatine par rapport au bévacizumab associé au paclitaxel et au carboplatine, comme traitement de première ligne, chez des patients ayant un cancer non squameux du poumon non à petites cellules avancé. [essai clos aux inclusions]
A venir
Country
France
organs
Poumon, type non à petites cellules
Specialty
Chimiothérapie
,
Immunothérapie - Vaccinothérapie
Essai clos aux inclusions
More information
Woman and Man Max 99 years
Pfizer Inc., 235 East 42nd Road, New York, NY 10017
Update Il y a 4 ans
Efficacy and Safety of Sunitinib in Patients with Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors
To confirm sunitinib treatment effect on progression-free survival (PFS) per investigator assessment in subjects with advanced/metastatic, well differentiated, unresectable, pancreatic neuroendocrine ...
Country
None
organs
None
Specialty
None
unknown
More information
Man
Between 18 years
and 99 years
Pfizer
Update Il y a 4 ans
Pfizer A6181120 : Essai de phase 3 randomisé, en double aveugle, comparant l’efficacité et la tolérance d’un traitement par prednisone avec ou sans sunitinib, chez des patients ayant un cancer de la prostate métastatique hormonorésistant. [essai clos aux inclusions]
L’objectif de cet essai est d’évaluer l’apport de l’association du sunitinib à la prednisone, sur l’efficacité et la tolérance du traitement, chez des patients ayant un cancer de la prostate métastati...
Country
France
organs
Prostate
Specialty
Thérapies Ciblées
,
Chimiothérapie
Essai clos aux inclusions
More information
Woman and Man
Between 18 years
and 99 years
Pfizer
Update Il y a 6 ans
Étude B9991005 : étude de phase 1b/2, en escalade de dose évaluant l’efficacité, la tolérance, la pharmacocinétique et la pharmacodynamique de l’avelumab en association avec le crizotinib ou le Pf-06463922, chez des patients ayant un cancer du poumon non à petites cellules avancé ou métastatique.
A venir
Country
France
organs
Poumon, type non à petites cellules
Specialty
Thérapies Ciblées
,
Immunothérapie - Vaccinothérapie
Essai ouvert aux inclusions
More information
Previous
1
2
3
4
5
6
7
8
9
10
Next